Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(±)8-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes. (±)8-HDHA is a potential marker of oxidative stress in brain and retina where DHA is an abundant polyunsaturated fatty acid.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 μg | 35 days | $ 193.00 | |
50 μg | 35 days | $ 360.00 | |
100 μg | 35 days | $ 683.00 | |
250 μg | 35 days | $ 1,500.00 |
Description | (±)8-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes. (±)8-HDHA is a potential marker of oxidative stress in brain and retina where DHA is an abundant polyunsaturated fatty acid. |
Molecular Weight | 344.495 |
Formula | C22H32O3 |
CAS No. | 90780-54-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PBS (pH 7.2): 0.8 mg/mL
DMSO: Miscible
Ethanol: Miscible
DMF: Miscible
0.1 M Na2CO3: 2 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(±)8-HDHA 90780-54-4 (±)8 HDHA 8-HDHA (±)8HDHA inhibitor inhibit